Dr Joshua Sabari Looks to the Future of Targeted Treatment for NSCLC
March 14th 2024March 1 saw the FDA grant full approval to amivantamab plus chemotherapy for first-line use in patients who have non–small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations, converting the May 2021 accelerated approval for this treatment in the second line.
Watch
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approval for NSCLC
March 4th 2024The approval converts the May 2021 accelerated FDA approval for second-line treatment of non–small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations to a full approval in the first line following results from the phase 3 PAPILLON study.
Watch
Getting to Know Dr Doug Marks, Oncology Clinical Trialist
February 20th 2024Douglas K. Marks, MD, is a breast medical oncologist and director of the Clinical Trials Office, Perlmutter Cancer Center, NYU Langone Hospital—Long Island, as well as associate professor in the Department of Medicine at NYU Grossman Long Island School of Medicine. As a phase 1 clinical trialist, he sees both patients with breast cancer and those who are looking to receive innovative treatments for their early-stage disease.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Telehealth During COVID-19: How Hospitals, Healthcare Providers Are Optimizing Virtual Care
March 14th 2020Amid the COVID-19 pandemic, patients, as well as their physicians, have been put at risk while seeking or providing other healthcare. While several barriers to care have inhibited telehealth in the past, recent actions by CMS, HHS, and other governing bodies have sought to expand its availability nationwide. NYU Langone Health's telehealth service Virtual Urgent Care connects members with clinicians via phone or tablet to provide care without potential coronavirus exposure.
Read More
NYU Researchers Find Blood Test Can Measure Effectiveness of Melanoma Treatments
May 16th 2019Researchers from the NYU School of Medicine and Perlmutter Cancer Center have determined that blood tests that track the amount of tumor DNA—after just 1 month of treatment—detect how well treatment is working in patients with skin cancer.
Read More
Family Health Centers at NYU Langone Aims to Improve Community Health Through Access to Food
May 13th 2019In an effort to improve food security and community health, Family Health Centers at NYU Langone has created a comprehensive program to provide a new nutritional resource to residents of Sunset Park, Brooklyn.
Read More
NYU Langone Creates Charity Fund for Complex Reconstructive Plastic Surgery for Patients in Need
May 1st 2019NYU Langone has created a charity care fund for patients in need of complex reconstructive plastic surgery through a $15.1 million donated from international businessman and philanthropist Hansjörg Wyss.
Read More
NYU-Led Study Finds Removal of Gene Prevents Development of Aggressive Pancreatic Cancer in Mice
May 1st 2019A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer.
Read More